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Autism spectrum disorders (ASD) comprise a number of heterogeneous
neurodevelopmental diseases characterized by core behavioral symptoms in the
domains of social interaction, language/communication and repetitive or stereotyped
patterns of behavior. In utero exposure to valproic acid (VPA) has evolved as a highly
recognized rodent ASD model due to the robust behavioral phenotype observed in
the offspring and the proven construct-, face- and predictive validity of the model.
The number of parvalbumin-immunoreactive (PV+) GABAergic interneurons has been
consistently reported to be decreased in human ASD subjects and in ASD animal
models. The presumed loss of this neuron subpopulation hereafter termed Pvalb
neurons and/or PV deficits were proposed to result in an excitation/inhibition imbalance
often observed in ASD. Importantly, loss of Pvalb neurons and decreased/absent PV
protein levels have two fundamentally different consequences. Thus, Pvalb neurons
were investigated in in utero VPA-exposed male (“VPA”) mice in the striatum, medial
prefrontal cortex (mPFC) and somatosensory cortex (SSC), three ASD-associated
brain regions. Unbiased stereology of PV+ neurons and Vicia Villosa Agglutinin-positive
(VVA+) perineuronal nets, which specifically enwrap Pvalb neurons, was carried out.
Analyses of PV protein expression and mRNA levels for Pvalb, Gad67, Kcnc1, Kcnc2,
Kcns3, Hcn1, Hcn2, and Hcn4 were performed. We found a ∼15% reduction in the
number of PV+ cells and decreased Pvalb mRNA and PV protein levels in the striatum
of VPA mice compared to controls, while the number of VVA+ cells was unchanged,
indicating that Pvalb neurons were affected at the level of the transcriptome. In selected
cortical regions (mPFC, SSC) of VPA mice, no quantitative loss/decrease of PV+ cells
was observed. However, expression of Kcnc1, coding for the voltage-gated potassium
channel Kv3.1 specifically expressed in Pvalb neurons, was decreased by ∼40% in
forebrain lysates of VPA mice. Moreover, hyperpolarization-activated cyclic nucleotide-
gated channel (HCN) 1 expression was increased by ∼40% in the same samples
from VPA mice. We conclude that VPA leads to alterations that are brain region-
and gene-specific including Pvalb, Kcnc1, and Hcn1 possibly linked to homeostatic
mechanisms. Striatal PV down-regulation appears as a common feature in a subset of
genetic (Shank3B-/-) and environmental ASD models.
Keywords: ASD, VPA, parvalbumin, Kv3, HCN, excitation/inhibition balance
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INTRODUCTION
Autism Spectrum Disorders (ASD) are a group of
neurodevelopmental disorders that share core behavioral
symptoms in the domains of social interaction,
language/communication and repetitive, or stereotyped
patterns of behavior (American Psychiatric Association,
2013). The etiology of ASD is still poorly understood;
ASD is viewed as a multifactorial disease, caused by a
combination of genetic, epigenetic, and environmental
cues. The genetics of ASD are extremely heterogeneous
with a large number (>100) of identified risk genes, yet
mutations in one of these risk genes occur sporadic and
do not affect more than 1–2% of ASD cases (Kleijer et al.,
2014; de la Torre-Ubieta et al., 2016). Environmental
insults during embryonic development and early postnatal
life are thus considered to play an important role in ASD
pathophysiology.
Valproic acid (VPA; also known as valproate) is used in
clinics for the treatment of epilepsy and psychiatric conditions
such as bipolar disorders and acute mania (Haddad et al.,
2009). Epidemiological studies in children have shown a
positive correlation between in utero VPA exposure and
the diagnosis of ASD (Bromley et al., 2013; Christensen
et al., 2013). VPA monotherapy during pregnancy results
in about seven-fold greater incidence of ASD or ASD key
symptoms including language impairment, reduced attention,
social deficits and restricted interests (Vinten et al., 2009).
The effects of VPA are thought to be induced by a broad
range of molecular mechanisms including: inhibition of histone
deacetylation (HDAC) (Phiel et al., 2001; Gottfried et al.,
2013), inositol depletion (Eickholt et al., 2005), increase
in fetal oxidative stress (Verrotti et al., 2008), changes in
gene expression (Ornoy, 2009) and induction of GABA
synthesis (Loscher, 1999). VPA exposure during pregnancy
has been extensively studied in rodents and has evolved
as the well-established “VPA mouse or rat model” for
the study of ASD. Behavioral phenotypes related to all
human core symptoms of ASD including impaired social
behavior, repetitive or stereotyped patterns of behavior and
impaired communication exist in juvenile VPA rats and
mice and persist into adulthood (reviewed in Roullet et al.,
2013; Ergaz et al., 2016). The striking and robust ASD
phenotype, together with the given construct validity, has
made it attractive for further studying the pathophysiology of
ASD.
Amongst other morpho-functional abnormalities, VPA mice
or rats were reported to exhibit a loss of PV-immunoreactive
(PV+) neurons in “PV-empty zones”, i.e., patchy zones devoid
of PV immunoreactivity observed on sections of the neocortex
(Gogolla et al., 2009); and in the colliculi superiors (Dendrinos
et al., 2011). Pvalb neuronal loss and/or decreased PV expression
has also been observed in post-mortem brains of human
ASD patients (Zikopoulos and Barbas, 2013; Stoner et al.,
2014; Hashemi et al., 2016) and various ASD mouse models
(see Table 1 in Wohr et al., 2015). PV is a calcium-binding
protein expressed in specific neurons in the brain (Celio,
1990) and for decades, PV has been used as a reliable
marker for a subset of GABAergic inhibitory neurons in
the CNS (Celio and Heizmann, 1981). In these neurons, PV
serves as a slow-onset Ca2+ buffer modulating several Ca2+-
dependent processes. PV−/− mice show alterations in synaptic
transmission including short-term plasticity, kinetics of delayed
transmitter release, precision of spike timing, excitability, as
well as other deviations (for review see Schwaller, 2012).
Moreover, Pvalb neurons in the cortex are essential players in
generating gamma band oscillations (Bartos et al., 2002; Buzsaki
and Wang, 2012). Selectively reducing Pvalb neuronal activity
strongly attenuates gamma oscillations, a phenomenon often
observed in ASD and schizophrenia patients during cognitive
tasks (Cho et al., 2006; Sohal et al., 2009). Although Pvalb
has never been described as an ASD risk gene, PV-deficient
(PV+/− and PV−/−) mice show a striking ASD phenotype
in all core domains (Wohr et al., 2015). Moreover, structural
MRI revealed ASD-associated neuroanatomical changes such
as transient cortical hypertrophy and cerebellar hypoplasia in
PV+/− and PV−/− mice (Wohr et al., 2015). Importantly,
Pvalb neurons in PV+/− and PV−/− mice (and also in the
validated ASD models Shank1−/− and Shank3B−/− mice)
are not lost, a conclusion often drawn too early when Pvalb
neurons are quantified solely using PV as marker. Rather,
PV expression levels might be low or absent, thus falling
under detection threshold, while the Pvalb neuron number
is unchanged. The latter was shown by stereological analysis
of perineuronal nets (PNNs), which represent an alternative
marker for Pvalb neurons or using PV-EGFP mice (Meyer
et al., 2002) expressing EGFP in Pvalb neurons independent
of endogenous PV expression levels (Filice et al., 2016). Here,
we investigated whether Pvalb neuron numbers were altered
and/or if PV expression was down-regulated in three ASD-
linked brain regions, namely the mPFC, SSC and striatum of
VPA male mice. Since these regions receive a vast number of
sensory inputs, they are crucial for multisensory integration,
executive function, language, social cognition, motivational
state and regulation of emotional behavior. Alterations in
the structure and function of the mPFC (Martinez-Sanchis,
2014), SSC (Markram and Markram, 2010; Khan et al.,
2016) and striatum (Fuccillo, 2016) have been consistently
reported in ASD. We found PV expression levels to be
decreased in the striatum, but not in forebrain lysates
comprising the two selected ASD-linked cortical regions. In all
3 brain regions, the number of Pvalb neurons was unchanged
between VPA and control mice, strongly arguing against a
loss of Pvalb neurons. VPA mice exhibited alterations in
the expression of potassium channels; mRNA and protein
levels of Kv3.1, selectively expressed in Pvalb neurons, was
decreased, whereas expression of hyperpolarization-activated
cyclic nucleotide gated-channel (HCN) 1 was up-regulated
in forebrain lysates. HCN channel-mediated Ih currents are
impaired in Shank3−/− mice (Yi et al., 2016), which exhibit
striatal PV downregulation similar to VPA mice as described in
this report. These changes are likely to affect the E/I balance that
is often altered in the brain of ASD subjects (Uhlhaas and Singer,
2007).
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MATERIALS AND METHODS
Animals
All mice were group-housed at the University of Fribourg,
Switzerland in temperature-controlled animal facilities (24◦C,
12:12 h light/dark cycle), fed ad libitum with free access to
water. C57Bl/6J mice were mated overnight until a vaginal plug
was detected in the morning. The day of sperm plug detection
was defined as gestational day 0 (GD0). At GD12, 600 mg/kg
valproic acid sodium salt (VPA; P4543 Sigma–Aldrich, Buchs,
Switzerland) diluted in 0.9% NaCl was administered by oral
gavage. Control animals were administered with 0.9% NaCl. Pups
were not weaned; brains were taken after cerebral dislocation
at postnatal day (PND) 25 ± 1. Only male mice were used
in this study. All experiments were performed with permission
of the local animal care committee (Canton of Fribourg,
Switzerland) and according to the present Swiss law and the
European Communities Council Directive of 24 November 1986
(86/609/EEC).
Tissue Preparation and
Immunohistochemistry
Mice at PND25 were anesthetized (Esconarkon, Streuli Pharma
AG, Uznach, Switzerland) and perfused with 0.9% saline solution
followed by 4% PFA. Brains were removed and post-fixed for
24 h in 4% PFA before being processed in 30% sucrose-TBS at
4◦C. After cryopreservation, coronal sections were cut rostro-
caudally using a freezing microtome (Frigomobil, Reichert-Jung,
Vienna, Austria); six series of equidistant sections were collected
using stereological systematic random sampling principles (see
below). Free-floating sections were initially blocked with TBS
0.1 M, pH 7.3 plus 0.4% Triton X-100 and 10% bovine serum
albumin (BSA) for 1 h at room temperature. Next, sections were
washed three times with TBS, and incubated with PV antibody
(anti-rabbit PV25, Swant, Marly, Switzerland) at a dilution of
1:1000 and with Vicia Villosa Agglutinin (biotinylated-VVA,
Reactolab, Servion, Switzerland) at a concentration of 10 µg/ml
in TBS containing MgCl2, MnCl2, CaCl2 (final salt concentration:
0.1 mM each) overnight at 4◦C. Sections were rinsed once
with TBS, then twice with Tris-HCl 0.1 M, pH 8.2; they were
then incubated (protected from light) at room temperature with
anti-rabbit Cy3-conjugated antibody (1:200 dilution) and Cy2
streptavidin-conjugated antibody (at a dilution of 1:200, from
Milan Analytic AG, Switzerland) in Tris-HCl. DAPI staining
allowed to visualize nuclei of fixed cells (1:1000 dilution, LuBio
Science GmbH, Luzern, Switzerland) in PBS 0.1 M, pH 7.4.
After final rinsing, slides were coverslipped with Hydromount
(National Diagnostics, Atlanta, GO, USA).
Stereological Quantification
We used the optical fractionator method (West et al., 1991)
to estimate the total number of PV-positive (PV+) and Vicia
Villosa Agglutinin-binding (VVA+) neurons in brain regions of
interest (ROIs) using the Stereo Investigator system (Version 11,
MicroBrightField, Williston, VT, USA). The Stereo Investigator
system was connected to a Zeiss Axioplan microscope with
a motorized x-y stage (Ludl Electronic Products, LTD, NY,
USA) and coupled to a Hamamtsu Orca Camera. ROIs were
defined based on stereotactic coordinates provided by the
Paxinos and Franklin atlas (Paxinos, 2001). The mPFC was
defined at 1.94 to 1.10 mm from bregma comprising the
anterior cingulate cortex, prelimbic area and infralimbic area;
the corpus callosum, the midline between the hemispheres and
fissura longitudinalis cerebri served as borders. The striatum
(caudoputamen) was defined at 1.10 to –0.82 mm from bregma;
the lateral ventricle, corpus callosum, capsula externa and globus
pallidus externum served as borders, whereas the commisura
anterior and rhinal fissure served as reference points. The
SSC was defined at 1.94 to –1.82 mm from bregma; the
corpus callosum and capsula externa served as borders, whereas
the lateral ventricle, cingulum, hippocampus and outer brain
curvature served as reference points. Cell counting was carried
out on images obtained with oil immersion objective lenses (100x;
NA = 1.40 and 63x; NA = 1.30). The volume of the analyzed
brain structure was determined using the Cavalieri estimator
(Gundersen et al., 1988). Five animals were analyzed per group,
with pups from at least 3 different litters for each group. All
results obtained from stereological quantification are reported in
Table 3.
Counting Criteria
Sampling parameters are reported in Table 1. VVA+ and PV+
cells were counted independently and according to the following
criteria: (1) Well visible DAPI-stained nucleus; (2) well-defined
perineuronal net (PNN) with a web-/lattice-like morphology for
VVA+ cells; examples are shown in Figure 1. (3) PV staining
surrounding the DAPI-stained nucleus for PV+ neurons. The
thickness of individual sections was measured at every fifth
sampling location, and the mean of all measurements was used
for all computations. At each selected location, the microscope
was focused down through the disector sample in order to count
any positive cell within that particular counting frame according
to disector counting rules. Of importance, the cell number
estimate is legitimate, even if the tissue volume changes during
processing, because the fractionator method does not necessitate
a measurement of tissue volume or any other dimensional
quality. The total number of cells (N) in the selected ROIs was
estimated as summarized by West et al. (1991, 1996) using the
equation:
N =
∑
Q− ×
(
1
ssf
)
×
(
1
asf
)
×
(
1
tsf
)
where Q− signifies the number of objects (counts), and ssf,
asf, and tsf correspond to the section sampling fraction, the
area sampling fraction and the thickness sampling fraction,
respectively. The accuracy of the estimates N is defined by the
coefficient of error CE (Table 1), which represents the sampling
error related to the counting noise, systematic uniform random
sampling and variances in section thickness (Gundersen et al.,
1999). For most biological samples, a CE value of 0.10 is largely
accepted. CEs for both m = 1 and m = 0 are provided in Table 1
and are expected to bracket the true CE values of the estimates. In
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our double-labeling experiments, strictly individual fluorescence
images for either PV+ or VVA+ structures were counted as
reported before (Filice et al., 2016) without crosschecking the
other channel. This ascertained that a cell (or a small part of a
cell resulting from the sectioning) with “weak” staining intensity
(i.e., below the predefined threshold) and/or characterized by
an “atypical” shape (not easily discernable as cell-like) was
considered negative, even if a check of the other channel would
have probably identified this cell/cell segment as positive for the
second marker.
RT-qPCR
Mice were euthanized by cervical dislocation and the brain was
quickly removed and put in ice-cold 0.9% saline solution. The
brain was cut in half along the midline and the cerebellum
was removed. The hippocampus and striatum were dissected
by carefully removing (pulling) these structures as described
in Supplementary Figure S2. The remaining parts of the brain
consisting essentially of cortex (approximately 80% of the total
volume) and to minor extent (<20%) subcortical structures
including thalamus and pallidum were collected as “forebrain”
samples. All tissue samples were snap-frozen in liquid nitrogen
and stored at –80◦C for further use. The left hemisphere was
always dissected first and used for qRT-PCR. Total RNA was
extracted from mouse brain tissue (striatum and “forebrain”
from the left hemisphere) using the peqGold TRIzol reagent
(Peqlab, VWR International GmbH, Erlangen, Germany). cDNA
was synthesized using ThermoFisher’s Verso cDNA Synthesis Kit
(ThermoFisher, Lausanne, Switzerland). qRT-PCR was carried
out to examine the expression of mRNA of the 18S rRNA, Ubc,
Pvalb, Gad67, Kcnc1, Kcnc2, Kcns3, Hcn1, Hcn2, and Hcn4 genes
using the universal 2X KAPA SYBR FAST qPCR Master Mix
(Axonlab AG, Mont-sur-Lausanne, Switzerland). Details about
the primer sequences are listed in Table 2. Gene expression
quantitation was carried out in a DNA thermal cycler (Corbett
Rotor gene 6000, QIAGEN Instruments AG, Hombrechtikon,
Switzerland), according to the following two-steps protocol: a
denaturation step of 95◦C for 3 min; 40 cycles of denaturation
at 95◦C for 3 s and annealing/extension/data acquisition ranging
from 52 to 62◦C for 20 s. The housekeeping genes 18S ribosomal
RNA (18S) or ubiquitin C (Ubc) were used as endogenous
controls to normalize the mRNA content for each sample. In the
second cohort of animals, Ubc mRNA signals were found to show
lower variability (smaller S.D.) compared to 18S, both within
individual animals and within the groups (VPA vs. control,
data not shown). Thus Ubc was used to normalize levels of
Kcnc2, Kcns3, Gad67, Hcn1, Hcn2, and Hcn4 mRNA levels in
the striatum of these animals. However, normalization with 18S
mRNA levels resulted in essentially similar values. mRNA levels
were quantified by the 2−11Ct method and normalized to (I)
housekeeping genes and furthermore (II) to the control mice
group as described before (Livak and Schmittgen, 2001).
Western Blot Analyses
Frozen brain tissue from the dissected second (right)
hemispheres as described above were homogenized and
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FIGURE 1 | Representative images of PV and VVA co-localization from PND25 mouse cortex. (A) PV+ cells (red) are enwrapped by VVA+ perineuronal nets
(green). Slices were counterstained with DAPI (blue). (B) Higher magnification of the boxes outlined in A. Arrowheads point at the PV+VVA+ double-positive cells that
are in focus. Scale bar: (A) 50 µm; (B) 20 µm.
TABLE 2 | qRT-PCR primers.
Primer Sequence 5′–3′ Nt position Gene Gene accession number
Pvalb For: TGTCGATGACAGACGTGCTC Rev: TTCTTCAACCCCAATCTTGC 24–43 309-328 Pvalb NM_013645
18S rRNA For: TCAAGAACGAAAGTCGGAGGTT Rev: GGACATCTAAGGGCATCACAG 1026–1047 1493-1513 Rn18S NR_003278
UBC For: CGGAGTCGCCCGAGGTCACA Rev: CTGCATCGTCTCTCTCACGGAGTT 23–42 94-117 Ubc NM_019639
GAD67 For: AATCTTGCTTCAGTAGCCTTCG Rev: TGTCTTCAAAAACACTTGTGGG 2979–3000 3178–3199 Gad1 NM_001312900
Kv3.1 For: GTGCCGACGAGTTCTTCTTC Rev: GTCATCTCCAGCTCGTCCTC 1362–1381 1646–1665 Kcnc1 NM_001112739
Kv3.2 For: AGATCGAGAGCAACGAGAGG Rev: GGTGGCGATCGAAGAAGAAT 72–91 379–398 Kcnc2 NM_001025581
Kv9.3 For: CCCTGGACAAGATGAGGAAC Rev: TTGATGCCCCAGTACTCGAT 465–484 745–764 Kcns3 NM_173417
HCN1 For: CTCAGTCTCTTGCGGTTATTACG Rev: TGGCGAGGTCATAGGTCAT 1138–1160 1210–1228 Hcn1 NM_010408
HCN2 For: ATCGCATAGGCAAGAAGAACTC Rev: CAATCTCCTGGATGATGGCATT 1936–1957 2017–2037 Hcn2 NM_008226
HCN4 For: GCATGATGCTTCTGCTGTGT Rev: GCTTCCCCCAGGAGTTATTC 1268–1287 1371–1390 Hcn4 NM_001081192
soluble or membrane proteins extracted for Western blotting
experiments as described before (Racay et al., 2006; Maetzler
et al., 2009). Denatured proteins (30 µg) were separated by
SDS-PAGE (10–12.5%). After electrophoresis, the proteins
were transferred on nitrocellulose membranes (MS solution,
Chemie Brunschwig, Basel, Switzerland). The membranes were
then blocked with 5% bovine serum albumin (BSA) in TBS
for 60 min at room temperature and incubated with primary
antibodies: rabbit anti-PV25 (Swant, Marly, Switzerland), rabbit
anti-GAPDH (Sigma–Aldrich, Buchs, Switzerland) diluted
1:10,000, rabbit anti-Kv3.1b (Merck Millipore, Schaffhausen,
Switzerland), rabbit anti-HCN1 (Alomone Labs, Jerusalem,
Israel) diluted 1:200 in 2% BSA in TBS-T overnight at 4◦C.
Membranes were washed three times in TBS-T and incubated
for 1 h with secondary antibody (goat anti-rabbit IgG HRP-
conjugated, Sigma–Aldrich, Buchs, Switzerland) diluted at
1:10,000 in TBS-T. Finally, membranes were repeatedly rinsed in
TBS-T and developed using ECL (Merck Millipore, Schaffhausen,
Switzerland). Bands visualized by ECL were quantified using
Image Studio Light Version 5.0. GAPDH signals were used as
loading control.
Statistical Analysis and Cell Number
Estimates
Stereological data, mRNA and protein levels were compared
between groups by the Student’s t-test. Data were analyzed
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using the GraphPad Prism 6 software (San Diego, USA). As
no significant differences were observed when comparing ROIs
in the two hemispheres of the same mouse, analyses were
carried out with the pooled data of both hemispheres. The
morphological data were initially checked for normal distribution
by the Kolmogorov–Smirnov test and further analyzed with the
Student’s t-test. A p-value < 0.05 was considered statistically
significant.
RESULTS
VPA-Treated Mice are Healthy and
Develop Normally
Different protocols for the VPA animal model of ASD have
been previously applied. We chose to use a dose of 600 mg/kg
administered at GD12, because of the well-described behavioral
phenotype observed in these mice (Gottfried et al., 2013;
Mabunga et al., 2015). Oral gavage was performed to accurately
control the dose and minimize risk to harm the pregnant females
or the fetus. We did not detect any physical malformation or
conspicuous features in the pups from VPA-treated mothers,
except for five pups from two different litters that manifested
few hairless spots at PND15. However, occurrence of hair
loss is a characteristic of the C57Bl/6J and related mouse
strains. Litter size, sex distribution and weight of the pups were
not different between VPA and control mice (Supplementary
Figure S1).
PV Expression Levels, But Not Pvalb
Neuron Numbers are Decreased in the
Striatum of VPA Mice
To evaluate the involvement of Pvalb neurons in the VPA mouse
model, we performed stereology-based analysis of VPA mice
at PND25 ± 1. The optical fractionator method was used to
reliably quantify cell numbers in three ASD-associated brain
regions, namely the striatum, medial prefrontal cortex (mPFC)
and somatosensory cortex (SSC). Coefficient of error (CE) values
ranged from 0.06 to 0.11 (Table 3) indicating a high precision of
the estimates for both PV+ and VVA+ populations (Gundersen
et al., 1999). One of the most crucial points when counting
PV+ cells stained with an anti-PV antibody, is, whether the
absence of a signal signifies “Pvalb neuron loss” or rather “PV
down-regulation”. Therefore, in addition to counting PV+ cells
via anti-PV immunostaining, we simultaneously quantified the
number of Vicia Villosa Agglutinin VVA+ cells, i.e., neurons
surrounded by PNNs in the same brain regions to obtain an
alternative estimate for the number of Pvalb cells. VVA is a
lectin that binds to N-acetylgalactosamine residues of PNNs,
which specifically surround Pvalb neurons (Hartig et al., 1992;
Haunso et al., 2000), as also shown in our previous study
(Filice et al., 2016). VVA+ cells were considered to serve as a
correlate for Pvalb neurons; a typical example of PV and VVA co-
localization is shown in Figure 1. In the selected cortical region,
essentially all PV+ cells are surrounded by a PNN identified
as VVA+ cells. The one cell showing strong PNN labeling, but
weak to none PV staining was mostly out of focus and cut very
tangentially, i.e. containing a minimal part of the somatic region
within the section, also evidenced by the low to absent DAPI
staining.
PV+ and VVA+ cells were counted independently without
crosschecking the other channel to ensure unbiased cell
estimates. In the striatum of control mice, ∼90% of PV+
cells were also VVA+ (Figure 2A), whereas in the cortex, the
selectivity was slightly lower with ∼75% of PV+ cells also
being positive for VVA (Figures 3A and 4A). Within the pool
of VVA+ cells, ∼70% and ∼65% of cells in control mice
were also identified as PV+ in the striatum (Figure 2A) and
the cortex (Figures 3A and 4A), respectively. Similar values
were obtained in previous studies (Ye and Miao, 2013; Filice
et al., 2016). The number of PV+ cells in the striatum of
VPA mice was reduced by ∼15% (p = 0.0093) compared to
controls (Figure 2A). However, there was no difference in
the number of VVA+ cells between the two groups in the
same region (Figure 2A), indicating that the number of Pvalb
neurons was not decreased in VPA mice. We thus determined
the number of double-labeled cells in the striatum. In saline-
treated control mice, 71% of VVA+ cells were also PV+,
whereas in VPA mice, this ratio was significantly decreased
TABLE 3 | Mean total number of PV+ and VVA+ cells in the striatum, SSC and mPFC of saline- and VPA-exposed mice.
Striatum PV+ Striatum VVA+
Mean SD P-value CEm = 0/m = 1 ≤ Mean SD P-value CEm = 0/m = 1 ≤
Control VPA 21′251 18’090 1051 1790 0.0093 0.09/0.06 0.10/0.07 26’518 27’225 460 3076 0.6249 0.09/0.06 0.09/0.06
SSC PV+ SSC VVA+
Mean SD P-value CEm = 0/m = 1 ≤ Mean SD P-value CEm = 0/m = 1 ≤
Control VPA 121′971 128′896 4987 14′897 0.3532 0.07/0.06 0.08/0.06 143’397 153’087 8093 13’281 0.2010 0.06/0.05 0.08/0.07
mPFC PV+ mPFC VVA+
Mean SD P-value CEm = 0/m = 1 ≤ Mean SD P-value CEm = 0/m = 1 ≤
Control VPA 6622 6760 242 1476 0.8415 0.11/0.07 0.10/0.07 7211 7380 713 1423 0.8191 0.10/0.07 0.11/0.07
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FIGURE 2 | (A) Left: Stereological estimations of PV+ (black) and VVA+ (gray) cells in the striatum of PND25 in utero saline-(CON) or VPA-treated male mice (N = 5
each). Significant differences are observed in PV+ cells between CON and VPA mice (P-value < 0.01). Asterisks represent ∗P ≤ 0.05, ∗∗P ≤ 0.01, respectively.
Middle: percentage of PV+ cells surrounded by VVA (black) and VVA+ cells showing PV expression (gray) in CON and VPA mice. Right: Volume of the ROI; i.e., the
striatum. (B) qRT-PCR values from PND25 mice representing striatal mRNA levels were normalized to 18S mRNA levels and expressed as fold change compared to
CON (N = 6 mice each). (C) Left: Quantitative Western blot analysis of striatal samples of PND25 CON and VPA mice (N = 6 each). Quantification of PV protein levels
in the striatum is shown. GAPDH signals served as loading controls and were used for the normalization of the PV signals. Results are expressed as a percentage of
normalized PV levels measured in a mixture of lysates from six WT striatums that was loaded on all membranes. Right: Representative Western blot signals. (D)
Representative PV immunofluorescence images from the striatum of a CON and VPA mouse are shown. Scale bar: 200 µm. All data expressed as mean ± SEM.
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FIGURE 3 | (A) Left: Stereological estimations of PV+ (black) and VVA+ (gray) cells in the SSC of PND25 in utero saline (CON) or VPA-treated male mice (N = 5
each). Middle: percentage of PV+ cells surrounded by VVA (black) and VVA+ cells showing PV expression (gray) in CON and VPA mice. Right: Volume of the ROI;
i.e., the SSC. (B) Representative PV immunofluorescence images from the SSC of a CON and VPA mouse are shown. Scale bar: 200 µm. All data are expressed as
mean ± SEM.
by ∼15% (p = 0.0448) (Figure 2A). This hinted that PV
protein expression levels might be down-regulated in VPA
mice. No difference was seen for PV-positive (PV+) cells
that also stained positive for VVA in the three investigated
regions (PV pool; Figures 2A, 3A, and 4A), suggesting that
globally VVA+ PNNs were not affected by VPA exposure.
Representative immunofluorescence images of the striatum are
shown in Figure 2D. Although cell estimates obtained by the
fractionator method are absolute, we decided to determine the
volume of the analyzed ROIs to exclude major macroscopically
discernable developmental abnormalities. The volume of the
striatum, as measured by the Cavalieri estimator, was not
different between VPA and control mice (Figure 2A). To
certify that PV expression was decreased in VPA mice, PV
levels were determined by qRT-PCR and Western blotting.
In line with the stereological counts, striatal Pvalb mRNA
levels were decreased by ∼50% (p = 0.0246) in VPA mice
compared to control animals (Figure 2B). Likewise, PV protein
expression levels in the striatum were decreased by ∼30%
(p = 0.0218) in VPA mice, fully supporting the stereological
findings (Figure 2C). GAPDH was used to normalize the PV
signals on the Western blots (Figure 2C). Since all Pvalb
neurons in the striatum are GABAergic and moreover express
the potassium voltage-gated channel subfamily C member 1
(KCNC1/Kv3.1) (Chow et al., 1999) and subfamily S member 3
(KCNS3/Kv9.3) (Georgiev et al., 2012), we quantified transcript
levels for glutamic acid decarboxylase 67 (Gad67), the major
GABA-synthetizing enzyme in the brain, Kcnc1 and Kcns3
in VPA and control mice. For all 3 Pvalb neuron markers,
transcript levels were not different in the striatum between VPA
and control mice (Figures 5B1,D,F). Altogether, these results
strongly indicated that VPA treatment resulted in decreased
striatal PV expression. Reduced PV expression was also shown
before in the striatum of PV+/− mice and moreover, in the
same region in Shank3B−/− knockout mice (Filice et al.,
2016).
Selected Cortical Regions (mPFC, SSC)
of VPA Mice Show Unaltered Pvalb
Neuron Numbers
Pvalb neurons in the rat and mouse VPA model have previously
been investigated and animals were reported to exhibit a
decreased number of PV+ cells, considered as the result of
Pvalb neuronal loss in the neocortex and the colliculi superior
(superficial and intermediate/deep layers), respectively (Gogolla
et al., 2009; Dendrinos et al., 2011). To confirm these findings,
but at the same time to investigate the alternate possibility that the
decrease in PV+ neurons was the result of PV down-regulation,
we examined two ASD-associated cortical structures, namely
SSC and mPFC. Stereological analysis of both regions did not
reveal altered numbers of Pvalb neurons in VPA compared to
control mice, since neither the number of PV+ cells nor the
one for VVA+ cells was different from control mice (Figures 3A
and 4A). Representative immunofluorescence images of the SSC
and mPFC are shown in Figures 3B and 4B, respectively.
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FIGURE 4 | (A) Left: Stereological estimations of PV+ (black) and VVA+ (gray) cells in the mPFC of PND25 in utero saline (CON) or VPA treated male mice (N = 5
each). Middle: percentage of PV+ cells surrounded by VVA (black) and VVA+ cells showing PV expression (gray) in CON and VPA mice. Right: Volume of the ROI;
i.e., the mPFC. Asterisks represent ∗P ≤ 0.05. (B) Representative PV immunofluorescence images from the mPFC of a CON and VPA mouse are shown. Scale bar:
200 µm. All data are expressed as mean ± SEM.
Of note, the volume of the mPFC was slightly increased by
∼20% (p = 0.0286) in VPA mice compared to control mice
(Figure 4A). Indeed, brain overgrowth during infancy is a
hallmark of ASD pathophysiology that has been observed in
human cases (Courchesne et al., 2011), in VPA mice (Go et al.,
2012) and several ASD mouse models including Shank3−/−
mice (Ellegood et al., 2015). Nonetheless, calculating the density
of Pvalb cells per unit volume did not result in a significantly
decreased number of Pvalb neurons in the mPFC of VPA mice.
The volume of the SSC was similar between VPA and control
mice (Figure 3A).
PV Expression Levels are Unchanged in
Forebrain Lysates, but Levels of Kv3.1b
are Decreased, While Levels of HCN1 are
Increased
Consistent with IHC stereology results from mPFC and SSC
(Figures 3 and 4) and global appearance of PV staining in the
cortex (data not shown), Pvalb mRNA and protein levels from
forebrain samples were similar between groups (Figure 5A1,A2).
To avoid cross-contamination, the forebrain tissue mostly
comprising neocortical tissue, but also including the subcortical
structures thalamus and pallidus was not further dissected;
thus, reduced spatial resolution is a limitation in the qRT-PCR
and Western blot analyses. Next, we quantified Gad67, Kcnc1
(Kv3.1), and Kcns3 (Kv9.3) mRNA levels in the forebrain samples.
Gad67 expression was not decreased in VPA mice; rather slightly
increased, supporting the finding that there was no loss of
GABAergic interneurons in VPA mice (Figure 5D). Moreover,
transcript levels of Kcns3, which is selectively expressed in Pvalb
neocortical neurons, were even slightly, but not significantly
(p = 0.1095) increased in VPA compared to control mice
(Figure 5F), in support of an unaltered (certainly not decreased)
number of Pvalb neurons. The precise localization of Kv9.3 giving
rise to a Kcns3 transcript signal in the striatum is currently
unknown. Irrespective of its origin, Kcns3 was unaltered in the
VPA mice (Figure 5F).
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FIGURE 5 | qRT-PCR values from PND25 mice representing mRNA levels for (A1) Pvalb, (B1) Kcnc1, (C1) Hcn1, (D) Gad67, (E) Kcnc2, (F) Kcns3, (G) Hcn2,
and (H) Hcn4 were normalized to 18S or Ubc mRNA levels and expressed as fold change compared to CON (N = 5 mice each; for Pvalb N = 6 mice each).
(A2,B2,C2) Quantitative Western blot analysis of forebrain samples of PND25 CON and VPA mice (N = 5 mice each). Quantification of PV (A2), Kv3.1b (B2), and
HCN1 (C2) protein levels in the forebrain samples are shown. Asterisks represent ∗P ≤ 0.05, ∗∗∗P ≤ 0.001. GAPDH signals served as loading controls and were
used for the normalization of the target protein signals. Results are expressed as a percentage of normalized PV/Kv3.1b/HCN1 levels measured in a mixture of
lysates from six WT forebrains that was loaded on all membranes. Representative Western blot signals for PV (A2), Kv3.1b (B2), and HCN1 (C2) are shown. All data
are expressed as mean ± SEM.
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In contrast, forebrain mRNA levels of Kcnc1 coding for
Kv3.1 were significantly decreased by ∼40% in VPA mice
(p = 0.0114) (Figure 5B1). This decrease was also confirmed at
the protein level: Kv3.1b protein levels determined by Western
blot analysis were decreased to a similar extent, i.e., ∼40%
reduction (p = 0.0002) of Kv3.1b in forebrain samples of
VPA mice compared to controls (Figure 5B2), a finding in
line with previous results from lysates of SSC of PND15-21
VPA mice (Iijima et al., 2016). We estimate that these results
reflect decreased expression of Kv3.1 channels rather than loss
of neurons expressing Kv3.1, since the overlap between cortical
Pvalb neurons (unchanged in mPFC and SSC; Figures 3A and
4A) and Kv3.1b is >95% (Chow et al., 1999). Since results
with respect to Pvalb neurons in VPA mice showed a high
similarity with what we had observed before in Shank3B−/−
mice, i.e., a significant decrease in striatal PV levels (Filice
et al., 2016) and moreover the recent findings that Shank3
mutations resulted in a decrease in hyperpolarization-activated
cation (Ih) currents likely being the result of decreased HCN3
and HCN4 levels (Yi et al., 2016), we investigated transcript levels
of the various hyperpolarization-activated cyclic nucleotide-
gated (HCN) channels in VPA mice including transcript levels
of Hcn1, Hcn2, and Hcn4, the predominant forms expressed
in the brain. While Hcn2 and Hcn4 transcript levels were
unchanged (Figures 5G,H); Hcn1, which does not co-localize
with Pvalb neurons in the neocortex and the basal ganglia
(Morris et al., 2004) was significantly up-regulated by ∼40%
(p = 0.0484) in forebrain samples of VPA mice (Figure 5C1).
The increase in HCN1 was also verified at the protein level;
Western blotting showed a ∼40% increase (p = 0.0342) in
VPA mice compared to controls (Figure 5C2). Interestingly,
when we quantitatively determined transcript levels of Hcn1,
Hcn2, and Hcn4 in the striatum, no differences were observed
between VPA and control mice (Figures 5C1,G,H). Finally,
we determined mRNA levels of Kcnc2 (Kv3.2) to see whether
Kv3.2 quantitatively compensates for the Kv3.1 deficit. Kv3.2 is
a close relative of Kv3.1, but co-localizes to a lesser extend with
Pvalb neurons (Chow et al., 1999). There was no difference in
forebrain mRNA levels of Kv3.2 between VPA and control mice
(Figure 5E). This was also true for the striatum (Figure 5E).
In summary, our results indicate that VPA mice do neither
exhibit Pvalb neuron loss nor a decrease in PV expression
levels in the forebrain; instead, they display reduced levels of
Kv3.1b in combination with augmented expression of HCN1. The
functional implications of these alterations in forebrain regions
including the neocortex and the selective down-regulation of
PV in the striatum, possibly linked to homeostatic plasticity, are
discussed below.
DISCUSSION
With far more than 100 putative risk genes and additionally
epigenetic and environmental risk factors, the pathophysiology
of ASD is extremely heterogeneous and complex. One of the
major current scientific aims is therefore to find common
pathways that link not only different risk genes, but also
epigenetic and environmental risk factors. During embryonic
development, not only genetic mutations may lead to aberrant
brain development, but also external insults may affect the
correct migration and differentiation of neuronal precursor
cells. This includes VPA shown to impair normal brain
development in humans as well as in rodents. Also at the
morpho-functional level, VPA mice and rats exhibit ASD-
specific abnormalities such as: decreased neuron numbers in
different brain areas (Rodier et al., 1996; Lukose et al., 2011;
Kataoka et al., 2013), an increase in a postsynaptic form of
long-term potentiation (LTP) between pyramidal cells in the
somatosensory cortex (Rinaldi et al., 2008), and deficits in
inhibitory signaling (Markram et al., 2008; Banerjee et al.,
2013). Altered synaptic transmission in VPA mice or rats is
of particular interest, since ASD are broadly characterized by
synaptic deficits leading to an E/I imbalance in the brain
(Rubenstein and Merzenich, 2003). Therefore, it is important
to explicitly address the question when, where and how
alterations/deficits in neuronal signaling occur in an ASD
model. In the VPA model, early postnatal enhancement of
NMDA receptor-mediated transmission and increased plasticity
in the SSC (Rinaldi et al., 2007) as well as hyper-connectivity
and hyper-plasticity of pyramidal synaptic connections in the
prefrontal cortex (Rinaldi et al., 2008) have been reported.
Intriguingly, in the same study, layer 5 pyramidal neurons in
∼PND14 mice were found to be less excitable in VPA animals
compared to controls (Rinaldi et al., 2008), a finding that was
confirmed in mice for layer 2/3 pyramidal neurons in the mPFC
(Walcott et al., 2011). Since the two developmental deviations
(increased NMDA receptor-mediated transmission and hypo-
excitability) show the same time line, it was hypothesized that
anomalies in one might lead to a homeostatic response to
the other (Walcott et al., 2011) according to the concept of
homeostatic synaptic plasticity (Turrigiano, 2011). Our observed
upregulation of HCN1 therefore might represent a possible
mechanism mediating such a transient change in intrinsic
neuronal properties leading to hypo-excitability secondary to
the observed hyper-connectivity and hyper-plasticity in the
mPFC in young mice according to findings reported by Rinaldi
(Rinaldi et al., 2008). The difference in intrinsic excitability
disappeared in adolescent (>1 month) mice demonstrating the
transient nature of plasticity mechanisms (Walcott et al., 2011).
In our study, we found increased levels of HCN1 in the cortex
of VPA mice. The various HCN channel members HCN1–4
differ in their tissue distribution, within the brain in particular
regions and neuron types and in their activation kinetics. They
are responsible for generating hyperpolarization-activated Ih
currents, important for controlling membrane resting potentials,
input resistance, dendritic integration, synaptic transmission
and neuronal excitability (Biel et al., 2009; Benarroch, 2013).
Elimination of HCN subunits or blocking of Ih currents
generally increases dendritic input resistance and leads to hyper-
excitability and enhanced neuronal firing (Shah et al., 2004;
Huang et al., 2009). Inversely, activity-dependent decrease of
excitability through enhancement of Ih currents is seen in rat
hippocampal neurons (Fan et al., 2005). Moreover, suppressed
burst-firing and decreased input resistance due to enhanced
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Ih currents have been observed in thalamo-cortical neurons
in the genetic absence epilepsy rat from Strasbourg (GAERS)
model, which shows upregulation of HCN1 protein levels (Kuisle
et al., 2006; Cain et al., 2015). Given that HCN1 is prominently
expressed in neocortical pyramidal cell dendrites (Moosmang
et al., 1999; Lorincz et al., 2002; Morris et al., 2004), increased
levels of HCN1 and subsequent enhancement of Ih currents
are likely to lower input resistance and thus might contribute
to the hypo-excitability observed in cortical pyramidal neurons
of VPA rats during the first month of development. Indeed,
membrane input resistance in the mPFC and SSC is slightly, yet
not significantly lower in VPA compared to control rats (Rinaldi
et al., 2008).
Also altered inhibitory signaling contributes to the
pathophysiology of ASD. Impaired pre- and post-synaptic
inhibitory transmission in the temporal cortex (Banerjee
et al., 2013), decreased inhibition in the lateral amygdala
(Markram et al., 2008) and a decrease in the PV+ neuron
number assumed to be the result of a loss of PV-expressing
neurons in the neocortex (Gogolla et al., 2009) and the colliculi
superiors (Dendrinos et al., 2011) have been observed in VPA
mice and rats. An involvement of the Pvalb neurons in ASD
and schizophrenia is nowadays undisputed. However, the
question whether Pvalb neurons are indeed lost or simply
deficient/reduced in PV protein levels is rarely addressed in an
appropriate way, e.g., by using other markers to unequivocally
identifying the Pvalb neuron population. Considering that the
two possibilities have opposite consequences, this is of great
importance: loss of Pvalb neurons leads to decreased inhibition,
whereas PV down-regulation has the opposite effect, i.e., by its
absence increasing short-term facilitation and thus enhancing
inhibition (Schwaller, 2012). Herein we have shown that the
number of Pvalb neurons, as determined by the number of VVA+
PNN-enwrapped cells, is unchanged in the striatum, mPFC and
SSC of VPA mice compared to controls. Thus, the reduced
numbers of PV+ neurons detected in the striatum of VPA mice
reflect decreased PV expression levels, also confirmed at mRNA
and protein levels, without any indication for Pvalb neuron loss.
While PV protein levels were clearly decreased in the striatum of
VPA mice, this didn’t occur in the cortex, where instead altered
expression of HCN1 and Kv3.1b was observed (see below). In
neurons, PV is essentially implicated in the subtle modulation
of Ca2+ signals and moreover involved in regulating the Ca2+
homeostasis and subsequently fine-tuning of neuronal signaling
(Schwaller, 2012). The absence of PV in PV−/− mice results in
enhanced facilitation and modified frequency-specific short-term
plasticity at FSI to striatal medium-sized spiny neuron synapses
(Orduz et al., 2013). Assuming a similar mechanism in VPA
mice, this might represent an adaptive/homeostatic mechanism
to strengthen impaired inhibitory signaling in the striatum of
VPA mice by enhancing the output of inhibitory Pvalb neurons.
Of note, the absence of PV not only affects the output of the FSI,
but also entails modifications in synaptic transmission between
the cortical afferences and striatal FSI; in PV−/− mice short-term
depression of EPSCs is increased in a similar time window (Wohr
et al., 2015) as short-term facilitation is increased in PV-FSI
(Orduz et al., 2013). We did not detect altered levels of PV in the
forebrain samples of VPA mice, in contrast to recent findings
by Iijima et al. (2016), who reported a decrease in PV levels by
>20% in lysates from neocortical cortex of PND15-21 mice.
This apparent discrepancy might be related to the time point of
their analyses: in the period from PND15-25, PV protein levels,
the number of PV-immunoreactive neurons or of Pvalb neuron
structures (e.g., boutons) increase considerably, e.g., seen in
mouse or rat cortex (Alcantara et al., 1993; de Lecea et al., 1995;
Huang et al., 1999), hippocampus (de Lecea et al., 1995; Chen
et al., 2014), and cerebellar Pvalb neurons (Collin et al., 2005). In
the reported cases adult levels were reached in the time window of
PND24-28, coinciding with the electrophysiological maturation
of GABAergic interneurons leveling off by the end of the 4th
week of development (Chattopadhyaya et al., 2004; Doischer
et al., 2008; Okaty et al., 2009). Yet, the precise trajectory of PV
expression levels and of functional Pvalb neuron maturation
in mouse SSC and mPFC are currently unknown. For a direct
comparison of VPA mice explored in this study with previously
investigated models such as Shank1−/−, Shank3B−/−, as well as
PV+/− and PV−/− mice (Filice et al., 2016), the latter having
also shown behavioral phenotypes with relevance to all ASD
core symptoms at PND25 (Wohr et al., 2015), we selected this
time point in our study. Of note, our forebrain lysates of PND25
mice that were used for quantification of RNA and protein levels
provide a lower spatial resolution than our results obtained by
stereological counts. Interestingly in PND70-80 mice having
reached adult PV expression levels with certainty, no differences
existed in SSC PV levels between VPA and control mice (Iijima
et al., 2016).
Both, mRNA and protein levels of Kv3.1b were significantly
decreased in forebrain extracts of VPA mice as also reported
for SSC recently (Iijima et al., 2016). In the mouse cortex,
Kv3.1b channels are exclusively expressed in Pvalb neurons
(99% of all PV+ neurons are Kv3.1b+ and vice versa (Chow
et al., 1999)), where they are necessary for maintaining the
fast-spiking phenotype of these neurons (Chow et al., 1999;
Hernandez-Pineda et al., 1999; Lien and Jonas, 2003). The next
closest relative, Kv3.2, is also expressed in Pvalb neurons, but its
distribution is more widespread. Not only is it expressed in other
interneuron types, but also in cortical glutamatergic inputs from
thalamo-cortical neurons (Chow et al., 1999). Kv3 channels are
voltage-gated K+ channels involved in the rapid repolarization
of the action potential (AP) mostly in fast-spiking neurons
(Lien and Jonas, 2003). Kv3.1 deficiency, or pharmacologically
blocking Kv3 channels, leads to broadening of AP duration due
to a reduced rate of repolarization resulting in a potentiation
of transmitter release (Erisir et al., 1999; Porcello et al., 2002;
Lien and Jonas, 2003; Jonas et al., 2004; Espinosa et al., 2008).
Resulting from the observed decrease of Kv3.1b in Pvalb neurons
leading to after-hyperpolarization (AHP) likely mediated by
Kv3.2 that are characterized by a 2−3 fold slower deactivation
kinetics compared to Kv3.1b, we hypothesize enhanced and
likely kinetically slower GABA release from Pvalb neurons.
Indeed, mIPSC kinetics in the temporal cortex of VPA rats are
significantly slower with respect to both rise and decay times
(Banerjee et al., 2013). Likely as a consequence of broadening
of AP, fast-frequency firing is severely compromised in neurons
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from Kv3.1−/− mice (Erisir et al., 1999; Porcello et al., 2002;
Lien and Jonas, 2003). This in turn leads to alterations in
oscillatory synchrony patterns, a function normally exerted by
Pvalb neurons, resulting in a gamma dys-synchrony phenotype
(Joho et al., 1999; Porcello et al., 2002), a feature often observed
in ASD (Uhlhaas and Singer, 2007). Of note, reductions in
gamma power are observed in hippocampal slices of PV−/−
mice in vitro (Vreugdenhil et al., 2003), however, the effects of
PV-deficiency on gamma oscillations in the cortex in vivo are
unknown.
Expression of Pvalb, Hcn1, and Kcnc1 genes are subject to
activity/experience-dependent regulation mechanisms (Fan et al.,
2005; Grabert and Wahle, 2009; Berridge, 2014). Consequently,
the observed alterations in expression levels of PV, HCN1, and
Kv3.1 are likely the result of altered brain development and most
probably altered neuronal signaling in VPA mice during early
postnatal development. The modifications brought about by VPA
are brain region-specific and include striatum, mPFC and SSC.
However, at the functional level, there appears to exist a certain
convergence. Both the decrease in PV in striatal Pvalb neurons, as
well as the decrease in Kv3.1b in forebrain Pvalb neurons might
be viewed as homeostatic mechanisms to augment Pvalb neuron-
mediated inhibition counteracting the hyper-connectivity and
hyper-plasticity observed in mPFC pyramidal neurons (Rinaldi
et al., 2008).
Interestingly, the decrease in cortical PV as well as Kv3.1
expression observed in the SSC of young (PND15–PND21)
VPA mice is no longer present in adult (PND70–PND90)
mice (Iijima et al., 2016). This would fit to the concept
of homeostatic plasticity, which suggests the presence of
adaptive/homeostatic regulatory mechanisms in the brain that
aim to maintain the stability and functionality of neural circuits
when challenged by environmental (e.g., VPA) or other insults
during development (Turrigiano, 2011). Such likely mechanisms
are operational in HCN1−/− mice; the absence of HCN1
resulted in an increase in background GABAA currents by up-
regulating GABAA α5 subunit expression (Chen et al., 2010).
According to our study, such homeostatic mechanisms are
brain region- and gene-specific in VPA mice. Further studies
including functional experiments and moreover determination
of expression profiles of, e.g., Kv3.1b, HCN1 in more precisely
defined brain regions (mPFC, SSC) need to be performed to
confirm these hypotheses.
Serving as the input structure of the basal ganglia, the
striatum receives a great number of sensory inputs and
participates in regulating motor control, behavioral flexibility,
motivational state, goal-directed learning, and attention. In
particular, striatal dysfunction is assumed to underlie repetitive
motor behaviors commonly seen in ASD (Fuccillo, 2016).
Striatal PV downregulation has previously been described in
PV+/− and Shank3B−/− mice (Filice et al., 2016) and both
of these models show a robust ASD phenotype including
repetitive or stereotyped patterns of behavior (Peca et al.,
2011; Wohr et al., 2015). Moreover, alterations in striatal
structure or function have been found in human ASD patients
(Langen et al., 2007; Estes et al., 2011) and multiple ASD
mouse model such as FMR1−/− (Centonze et al., 2008),
Shank3−/− (Peca et al., 2011), CNTNAP2−/− (Penagarikano
et al., 2011), CNTNAP4−/− (Karayannis et al., 2014), and
VPA rats (Schneider et al., 2007). Taken together, striatal PV
downregulation represents a promising cellular/morphological
phenotype overlapping between different ASD models. It remains
to be shown whether alterations in PV, HCN1 and Kv3.1 are
common to other ASD models and/or observed in human ASD
subjects and whether they persist into adulthood. If confirmed,
the three genes might represent attractive targets for novel
therapeutic strategies in ASD.
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